Glucocorticoid-induced osteoporosis in children with 21-hydroxylase deficiency (Q26821908)

Maria Felicia Faienza

8

0 references

Silvia Colucci

Silvia Colucci

3

0 references

Luciano Cavallo

Luciano Cavallo

6

0 references

Maria Grano

Maria Grano

7

0 references

author name string

Annamaria Ventura

1

1 reference

Angela Oranger

4

1 reference

Filomena Ladisa

5

1 reference

language of work or name

1 reference

2013

1 reference

BioMed Research International

8 January 2013

13 references

13 March 2019

24 March 2019

22 April 2019

7 August 2019

28 September 2019

12 October 2019

17 November 2019

18 November 2019

14 December 2019

29 May 2020

15 July 2020

20 December 2020

3 October 2022

13 references

13 March 2019

24 March 2019

22 April 2019

7 August 2019

28 September 2019

12 October 2019

17 November 2019

18 November 2019

14 December 2019

15 July 2020

20 December 2020

3 October 2022

2013

1 reference

page(s)

250462

1 reference

Creative Commons Attribution 3.0 Unported

copyright license

13 references

13 March 2019

24 March 2019

22 April 2019

7 August 2019

28 September 2019

12 October 2019

17 November 2019

18 November 2019

14 December 2019

29 May 2020

15 July 2020

20 December 2020

on focus list of Wikimedia project

3 October 2022

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Bone morphogenetic proteins

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Essential role of beta-catenin in postnatal bone acquisition

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Osteoclast differentiation and activation

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Glucocorticoid receptor signaling in bone cells

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Steroid 21 hydroxylase deficiency congenital adrenal hyperplasia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

The roles of cyclic nucleotide phosphodiesterases (PDEs) in steroidogenesis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Advances in glucocorticoid-induced osteoporosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

A Summary of the Endocrine Society Clinical Practice Guidelines on Congenital Adrenal Hyperplasia due to Steroid 21-Hydroxylase Deficiency

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Bone health should be an important concern in the care of patients affected by 21 hydroxylase deficiency

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

28 September 2017

Adrenal gland and bone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Decreased bone mineral density and vertebral compression fractures in a young adult male with 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH): is CAH an unrecognized population at risk for glucocorticoid-induced osteoporosis?

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Genetics of congenital adrenal hyperplasia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Tissue-specific glucocorticoid action: a family affair

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Nuclear receptor drug discovery

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Crosstalk between the glucocorticoid receptor and other transcription factors: molecular aspects.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Glucocorticoid-induced osteoporosis: pathophysiology and therapy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Extensive clinical experience: nonclassical 21-hydroxylase deficiency

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Glucocorticoid-induced osteoporosis: an update

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Protein inhibitor of activated STAT3 inhibits adipogenic gene expression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

A fully dissociated compound of plant origin for inflammatory gene repression

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Mechanisms of glucocorticoid receptor action in noninflammatory and inflammatory cells

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Perspectives on glucocorticoid-induced osteoporosis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Normal bone mineral content in young adults with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

CYP21 mutations and congenital adrenal hyperplasia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Congenital adrenal hyperplasia due to 21-hydroxylase deficiency

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Human osteoclasts derive from CD14-positive monocytes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Genetic diseases of steroid metabolism

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Regulation of Bone Formation

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

17 alpha-hydroxylase/17,20-lyase deficiency: from clinical investigation to molecular definition

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Glucocorticoids inhibit developmental stage-specific osteoblast cell cycle. Dissociation of cyclin A-cyclin-dependent kinase 2 from E2F4-p130 complexes

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Identification and characterization of two proximal elements in the rat osteocalcin gene promoter that may confer species-specific regulation

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Effects off short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

The glucocorticoid receptor binds to a sequence overlapping the TATA box of the human osteocalcin promoter: a potential mechanism for negative regulation

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency

31 May 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F250462

Congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F250462

Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F250462

Cortisol downregulates osteoblast alpha 1 (I) procollagen mRNA by transcriptional and posttranscriptional mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F250462

Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F250462

Regulation of bim in glucocorticoid-mediated osteoblast apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F250462

Prevention of glucocorticoid-induced apoptosis in osteocytes and osteoblasts by calbindin-D28k.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F250462

Stimulation of osteoclast differentiation in vitro by mouse oncostatin M, leukaemia inhibitory factor, cardiotrophin-1 and interleukin 6: synergy with dexamethasone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F250462

Dexamethasone enhances osteoclast formation synergistically with transforming growth factor-beta by stimulating the priming of osteoclast progenitors for differentiation into osteoclasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F250462

Selective glucocorticoid receptor modulation maintains bone mineral density in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F250462

Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a cross-sectional study of factors involved in bone mineral density

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F250462

Long-term corticosteroid replacement and bone mineral density in adult women with classical congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F250462

Fractures and bone mineral density in adult women with 21-hydroxylase deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F250462

Bone mineral density and bone turnover in Romanian children and young adults with classical 21-hydroxylase deficiency are influenced by glucocorticoid replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F250462

Bone density in young patients with congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F250462

Bone mineral density in prepubertal and in adolescent and young adult patients with the salt-wasting form of congenital adrenal hyperplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F250462

Normal bone mineral density and lean body mass, but increased fat mass, in young adult patients with congenital adrenal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F250462

Osteoclastogenesis in children with 21-hydroxylase deficiency on long-term glucocorticoid therapy: the role of receptor activator of nuclear factor-kappaB ligand/osteoprotegerin imbalance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2013%2F250462

High dickkopf-1 levels in sera and leukocytes from children with 21-hydroxylase deficiency on chronic glucocorticoid treatment.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Novel mutations in CYP21 detected in individuals with hyperandrogenism.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Height, bone mineral density and bone markers in congenital adrenal hyperplasia

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3581245

Oxidized LDL induces the expression of ALBP/aP2 mRNA and protein in human THP-1 macrophages

28 November 2018

1 reference

12 December 2020

The effects of glucocorticoid replacement therapy on growth, bone mineral density, and bone turnover markers in children with congenital adrenal hyperplasia

1 reference

12 December 2020

Preliminary report: effect of adrenal androgen and estrogen on bone maturation and bone mineral density

1 reference

12 December 2020

Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency

1 reference

12 December 2020

Mechanisms of glucocorticoid action in bone

1 reference

12 December 2020

Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency

1 reference

12 December 2020

Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy

1 reference

12 December 2020

Bone mineral density and body composition in congenital adrenal hyperplasia

1 reference

12 December 2020

https://api.fatcat.wiki/v0/release/477lq46t6fegzazam7svbhljta

Identifiers

1 reference

30 July 2022

release_477lq46t6fegzazam7svbhljta

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/477lq46t6fegzazam7svbhljta

30 July 2022

https://api.fatcat.wiki/v0/release/477lq46t6fegzazam7svbhljta

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/477lq46t6fegzazam7svbhljta

1 reference

30 July 2022